Romeo C Agbayani, MD
Otolaryngology · Greenbrae
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 1 carrier
- Offices
- 3
- Since medical school
- 33 years
- Tufts University School of Medicine, 1993
Offices
3 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
8 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agbayani’s office at (925) 932-6330 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G81045 · Current
Licensed to practise in California · since 1995 · expires 2027-03-31 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$263,186
Medicare paid this office $263,186 for 1,236 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 459 | $55,324 | $74 |
| Diagnostic exam of nasal passages using an endoscope | 203 | $43,223 | $172 |
| New patient visit (30+ min) | 432 | $37,491 | $87 |
| Removal of impacted ear wax | 475 | $31,272 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 101 | $13,865 | $115 |
See all 17 services
| Short return visit (20+ min) | 459 | $55,324 | $74 |
| Diagnostic exam of nasal passages using an endoscope | 203 | $43,223 | $172 |
| New patient visit (30+ min) | 432 | $37,491 | $87 |
| Removal of impacted ear wax | 475 | $31,272 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 101 | $13,865 | $115 |
| Return visit (30+ min) | 106 | $11,761 | $102 |
| Comprehensive hearing and speech recognition test | 334 | $11,321 | $29 |
| New patient visit (45+ min) | 59 | $7,280 | $123 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 20 | $4,193 | $200 |
| Long return visit (40+ min) | 23 | $3,568 | $149 |
| Simple control of nose bleed | 23 | $3,525 | $136 |
| New patient visit (15+ min) | 67 | $3,444 | $51 |
| Test for eardrum and muscle function | 178 | $3,158 | $17 |
| Test to assess middle ear function | 162 | $2,946 | $14 |
| Exam of ear using a microscope | 44 | $1,791 | $26 |
| Removal of foreign body in ear canal | 22 | $1,638 | $68 |
| Short return visit | 11 | $604 | $50 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Spinal fusion | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 668 | 623 | 774 | 767 | 778 | 831 |
| Diagnostic exam of nasal passages using an endoscope | 160 | 124 | 197 | 198 | 239 | 252 |
| Diagnostic exam of voice box using a flexible endoscope | 199 | 174 | 226 | 176 | 164 | 121 |
| Removal of foreign body in ear canal | 14 | 14 | 22 | 13 | 24 | 24 |
| Simple control of nose bleed | – | 15 | 17 | – | – | 26 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | – | – | – | – | 22 | 21 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,236 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 21% · Women 55% · Also on Medicaid 7% · Health risk score 1.02. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 61% · Coronary heart disease 25% · Atrial fibrillation 19% · Depression 17% · Chronic kidney disease 16% · Cancer 16% · Diabetes 14% · Heart failure 9% · COPD 9% · Stroke 9% · Dementia 6%.
The office billed $758,211, Medicare allowed $363,406 and paid $263,186; for 3,763 services of 70 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,236 | 3,763 | 78 | 1.02 | $758,211 | $263,186 |
| 2023 | 1,257 | 3,718 | 78 | 1.02 | $710,112 | $277,576 |
| 2022 | 1,211 | 3,306 | 77 | 0.99 | $645,640 | $258,309 |
| 2021 | 1,288 | 3,634 | 77 | 0.96 | $734,665 | $287,807 |
| 2020 | 1,091 | 3,123 | 77 | 1.04 | $623,101 | $231,663 |
| 2019 | 1,012 | 3,077 | 77 | 1.03 | $680,942 | $231,861 |
| 2018 | 748 | 2,029 | 78 | 1.06 | $474,678 | $145,387 |
| 2017 | 831 | 2,351 | 77 | 1.03 | $539,150 | $160,456 |
| 2016 | 1,010 | 2,553 | 77 | 1.09 | $539,901 | $177,586 |
| 2015 | 918 | 2,164 | 77 | 1.06 | $375,741 | $150,155 |
| 2014 | 949 | 2,475 | 78 | 0.94 | $403,138 | $172,580 |
| 2013 | 657 | 1,562 | 76 | 1.02 | $261,527 | $122,434 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Short return visit (20+ min) | 472 | $58,037 | $79 |
| Diagnostic exam of nasal passages using an endoscope | 185 | $44,443 | $186 |
| New patient visit (30+ min) | 438 | $38,632 | $88 |
| Removal of impacted ear wax | 439 | $28,528 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 135 | $20,323 | $124 |
| Return visit (30+ min) | 121 | $14,889 | $112 |
| Comprehensive hearing and speech recognition test | 355 | $12,737 | $32 |
| New patient visit (45+ min) | 71 | $10,049 | $142 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 20 | $4,607 | $209 |
| Long return visit (40+ min) | 24 | $4,520 | $167 |
| Test to assess middle ear function | 206 | $3,949 | $15 |
| New patient visit (15+ min) | 61 | $3,787 | $62 |
| Test for eardrum and muscle function | 171 | $3,379 | $19 |
| New patient visit (60+ min) | 15 | $3,053 | $204 |
| Exam of ear using a microscope | 47 | $1,597 | $29 |
| Removal of foreign body in ear canal | 24 | $1,425 | $59 |
2022: 14 services
| Short return visit (20+ min) | 408 | $46,733 | $81 |
| Diagnostic exam of nasal passages using an endoscope | 160 | $37,332 | $189 |
| New patient visit (30+ min) | 387 | $35,774 | $92 |
| Removal of impacted ear wax | 449 | $27,994 | $36 |
| Diagnostic exam of voice box using a flexible endoscope | 139 | $22,289 | $127 |
| Return visit (30+ min) | 136 | $18,060 | $113 |
| New patient visit (45+ min) | 122 | $17,157 | $141 |
| Comprehensive hearing and speech recognition test | 308 | $10,981 | $33 |
| Test for eardrum and muscle function | 180 | $3,556 | $20 |
| Long return visit (40+ min) | 17 | $2,733 | $152 |
| Test to assess middle ear function | 128 | $2,262 | $16 |
| Exam of ear using a microscope | 32 | $1,668 | $29 |
| New patient visit (15+ min) | 27 | $1,595 | $59 |
| Removal of foreign body in ear canal | 13 | $1,023 | $79 |
2021: 18 services
| Short return visit (20+ min) | 460 | $51,975 | $79 |
| Diagnostic exam of nasal passages using an endoscope | 163 | $38,035 | $193 |
| New patient visit (30+ min) | 423 | $37,669 | $89 |
| Removal of impacted ear wax | 444 | $29,081 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 173 | $28,360 | $125 |
| New patient visit (45+ min) | 124 | $17,354 | $140 |
| Return visit (30+ min) | 112 | $13,625 | $110 |
| Comprehensive hearing and speech recognition test | 338 | $12,328 | $34 |
| Control of bleeding of nose using an endoscope | 14 | $3,827 | $239 |
| Test for eardrum and muscle function | 184 | $3,785 | $20 |
| New patient visit (15+ min) | 67 | $3,730 | $56 |
| Simple control of nose bleed | 13 | $2,463 | $145 |
| Long return visit (40+ min) | 15 | $2,367 | $158 |
| Test to assess middle ear function | 133 | $2,320 | $15 |
| Exam of ear using a microscope | 52 | $1,622 | $28 |
| Removal of foreign body in ear canal | 21 | $1,524 | $69 |
| Short return visit | 21 | $1,129 | $51 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $378 | $34 |
2020: 17 services
| New patient visit (30+ min) | 409 | $36,238 | $89 |
| Short return visit (20+ min) | 305 | $28,492 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 106 | $23,019 | $186 |
| Removal of impacted ear wax | 367 | $22,811 | $37 |
| Return visit (30+ min) | 180 | $21,282 | $89 |
| Diagnostic exam of voice box using a flexible endoscope | 143 | $20,403 | $117 |
| New patient visit (45+ min) | 84 | $11,953 | $142 |
| Comprehensive hearing and speech recognition test | 258 | $9,967 | $34 |
| Long return visit (40+ min) | 25 | $4,123 | $133 |
| New patient visit (15+ min) | 65 | $3,898 | $60 |
| Test to assess middle ear function | 171 | $3,020 | $14 |
| Test for eardrum and muscle function | 98 | $1,989 | $20 |
| Simple control of nose bleed | 13 | $1,914 | $128 |
| Ultrasound scan of head and neck soft tissue | 13 | $1,640 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,344 | $122 |
| Removal of foreign body in ear canal | 12 | $1,024 | $73 |
| Short return visit | 13 | $522 | $37 |
2019: 18 services
| Diagnostic exam of nasal passages using an endoscope | 133 | $30,564 | $191 |
| New patient visit (30+ min) | 363 | $30,184 | $83 |
| Short return visit (20+ min) | 297 | $29,309 | $65 |
| Removal of impacted ear wax | 377 | $25,611 | $38 |
| Return visit (30+ min) | 158 | $20,933 | $95 |
| Diagnostic exam of voice box using a flexible endoscope | 156 | $20,318 | $102 |
| Comprehensive hearing and speech recognition test | 250 | $9,305 | $32 |
| New patient visit (45+ min) | 49 | $6,182 | $126 |
| Long return visit (40+ min) | 21 | $2,974 | $124 |
| New patient visit (15+ min) | 47 | $2,827 | $60 |
| Test to assess middle ear function | 149 | $2,612 | $13 |
| Evaluation and testing for balance with recording | 15 | $1,450 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,431 | $119 |
| Ultrasound scan of head and neck soft tissue | 12 | $1,369 | $81 |
| Test for eardrum and muscle function | 59 | $1,000 | $17 |
| Removal of foreign body in ear canal | 13 | $935 | $67 |
| Short return visit | 20 | $847 | $37 |
| Exam of ear using a microscope | 13 | $434 | $26 |
2018: 15 services
| Removal of impacted ear wax | 310 | $20,856 | $36 |
| Return visit (30+ min) | 154 | $16,880 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 67 | $15,782 | $188 |
| Short return visit (20+ min) | 180 | $14,785 | $58 |
| Diagnostic exam of voice box using a flexible endoscope | 105 | $13,014 | $97 |
| New patient visit (30+ min) | 140 | $11,284 | $81 |
| Comprehensive hearing and speech recognition test | 201 | $6,372 | $30 |
| Exam to assess movement of vocal cord flaps using an endoscope | 17 | $3,128 | $156 |
| Long return visit (40+ min) | 21 | $2,477 | $113 |
| New patient visit (45+ min) | 16 | $2,016 | $126 |
| New patient visit (15+ min) | 31 | $1,753 | $57 |
| Ultrasound scan of head and neck soft tissue | 11 | $1,251 | $104 |
| Short return visit | 30 | $1,124 | $33 |
| Test for eardrum and muscle function | 62 | $1,062 | $17 |
| Test to assess middle ear function | 43 | $575 | $12 |
2017: 15 services
| Removal of impacted ear wax | 370 | $23,590 | $37 |
| Short return visit (20+ min) | 265 | $21,390 | $57 |
| Diagnostic exam of nasal passages using an endoscope | 79 | $19,688 | $182 |
| New patient visit (30+ min) | 194 | $15,556 | $80 |
| Return visit (30+ min) | 127 | $14,000 | $86 |
| Diagnostic exam of voice box using a flexible endoscope | 123 | $13,772 | $94 |
| Comprehensive hearing and speech recognition test | 260 | $8,280 | $29 |
| Exam to assess movement of vocal cord flaps using an endoscope | 14 | $4,460 | $149 |
| New patient visit (45+ min) | 22 | $2,839 | $129 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 11 | $2,183 | $168 |
| Long return visit (40+ min) | 14 | $1,815 | $113 |
| Short return visit | 42 | $1,668 | $35 |
| New patient visit (15+ min) | 24 | $1,438 | $60 |
| Test for eardrum and muscle function | 51 | $799 | $15 |
| Test to assess middle ear function | 58 | $764 | $12 |
2016: 18 services
| Removal of impacted ear wax | 396 | $27,935 | $40 |
| Diagnostic exam of nasal passages using an endoscope | 73 | $17,972 | $191 |
| New patient visit (45+ min) | 122 | $16,616 | $136 |
| Diagnostic exam of voice box using a flexible endoscope | 141 | $16,529 | $97 |
| Short return visit | 248 | $13,614 | $37 |
| New patient visit (30+ min) | 141 | $13,105 | $93 |
| Short return visit (20+ min) | 158 | $12,639 | $63 |
| Comprehensive hearing and speech recognition test | 259 | $8,819 | $31 |
| Return visit (30+ min) | 61 | $6,458 | $92 |
| Exam to assess movement of vocal cord flaps using an endoscope | 13 | $2,927 | $172 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 15 | $2,765 | $184 |
| New patient visit (60+ min) | 13 | $2,160 | $166 |
| Long return visit (40+ min) | 16 | $2,125 | $125 |
| Simple control of nose bleed | 12 | $1,346 | $84 |
| New patient visit (15+ min) | 21 | $1,308 | $62 |
| Test to assess middle ear function | 89 | $1,242 | $13 |
| Test for eardrum and muscle function | 53 | $910 | $17 |
| Removal of foreign body in ear canal | 11 | $892 | $81 |
2015: 13 services
| Removal of impacted ear wax | 395 | $28,005 | $39 |
| Short return visit (20+ min) | 316 | $26,536 | $61 |
| New patient visit (45+ min) | 124 | $17,019 | $137 |
| Diagnostic exam of nasal passages using an endoscope | 61 | $14,771 | $197 |
| Diagnostic exam of voice box using a flexible endoscope | 93 | $11,588 | $103 |
| Comprehensive hearing and speech recognition test | 215 | $7,000 | $31 |
| New patient visit (30+ min) | 58 | $4,998 | $86 |
| Exam to assess movement of vocal cord flaps using an endoscope | 20 | $4,750 | $183 |
| Short return visit | 103 | $4,660 | $39 |
| Long return visit (40+ min) | 11 | $1,389 | $126 |
| Simple control of nose bleed | 11 | $1,293 | $86 |
| Test to assess middle ear function | 60 | $812 | $12 |
| Test for eardrum and muscle function | 32 | $602 | $18 |
2014: 17 services
| Removal of impacted ear wax | 443 | $32,447 | $40 |
| Short return visit (20+ min) | 297 | $25,048 | $61 |
| Diagnostic exam of nasal passages using an endoscope | 61 | $15,943 | $197 |
| New patient visit (45+ min) | 110 | $15,245 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 102 | $13,105 | $102 |
| New patient visit (30+ min) | 93 | $8,133 | $87 |
| Comprehensive hearing and speech recognition test | 230 | $7,935 | $31 |
| Exam to assess movement of vocal cord flaps using an endoscope | 26 | $6,330 | $192 |
| Short return visit | 133 | $5,809 | $36 |
| Return visit (30+ min) | 29 | $3,291 | $94 |
| New patient visit (60+ min) | 16 | $2,723 | $170 |
| Long return visit (40+ min) | 12 | $1,505 | $125 |
| Simple control of nose bleed | 11 | $1,150 | $82 |
| Test to assess middle ear function | 77 | $1,059 | $12 |
| New patient visit (15+ min) | 17 | $787 | $46 |
| Test for eardrum and muscle function | 40 | $751 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $344 | $18 |
2013: 14 services
| Short return visit (20+ min) | 209 | $17,993 | $61 |
| Removal of impacted ear wax | 208 | $13,116 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 100 | $11,927 | $106 |
| Diagnostic exam of nasal passages using an endoscope | 50 | $11,888 | $205 |
| New patient visit (45+ min) | 78 | $10,915 | $140 |
| New patient visit (30+ min) | 115 | $10,051 | $87 |
| Short return visit | 104 | $4,767 | $38 |
| Comprehensive hearing and speech recognition test | 135 | $4,728 | $32 |
| New patient visit (60+ min) | 17 | $2,895 | $170 |
| New patient visit (15+ min) | 24 | $1,529 | $64 |
| Return visit (30+ min) | 13 | $1,233 | $95 |
| Test to assess middle ear function | 71 | $1,099 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $453 | $19 |
| Test for eardrum and muscle function | 11 | $201 | $18 |
Drugs they prescribed that Part D paid
$96,529
Pharmacies billed $96,529 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (21 of 375) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
314 generic and fewer than 11 brand-name prescriptions · $96,529 in drug cost · 75 antibiotic prescriptions to 49 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 20 | $82,058 | $4,103 |
| Ciprofloxacin-Dexamethasone | 46 | $5,187 | $113 |
| Ipratropium | 76 | $3,566 | $47 |
| Azelastine | 15 | $676 | $45 |
| Omeprazole | 16 | $372 | $23 |
See all 9 drugs
| Dupixent | 20 | $82,058 | $4,103 |
| Ciprofloxacin-Dexamethasone | 46 | $5,187 | $113 |
| Ipratropium | 76 | $3,566 | $47 |
| Azelastine | 15 | $676 | $45 |
| Omeprazole | 16 | $372 | $23 |
| Amoxicillin-Clavulanate Potass | 37 | $292 | $8 |
| Doxycycline Hyclate | 13 | $191 | $15 |
| Prednisone | 24 | $184 | $8 |
| Hydrocodone-Acetaminophen | 21 | $160 | $8 |
Year by year
| 2024 | 375 | 147 | 6% (21) | None | $96,529 |
| 2023 | 285 | 125 | 5% (15) | 4% | $44,245 |
| 2022 | 282 | 143 | 6% (16) | 8% | $14,945 |
| 2021 | 222 | 109 | None | 8% | $20,301 |
| 2020 | 177 | 93 | None | 10% | $8,811 |
| 2019 | 222 | 107 | None | 9% | $8,973 |
| 2018 | 272 | 111 | 6% (15) | 10% | $13,560 |
| 2017 | 302 | 119 | 6% (19) | 12% | $17,950 |
| 2016 | 325 | 135 | 4% (12) | 22% | $28,634 |
| 2015 | 307 | 134 | None | 35% | $35,707 |
| 2014 | 409 | 172 | 9% (38) | 36% | $44,588 |
| 2013 | 332 | 140 | 5% (16) | 46% | $38,657 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Ipratropium | 74 | $4,893 | $66 |
| Ciprofloxacin-Dexamethasone | 12 | $1,722 | $143 |
| Fluticasone Propionate | 24 | $603 | $25 |
| Azelastine | 13 | $529 | $41 |
| Amoxicillin-Clavulanate Potass | 28 | $287 | $10 |
| Doxycycline Hyclate | 11 | $172 | $16 |
| Prednisone | 16 | $148 | $9 |
| Hydrocodone-Acetaminophen | 15 | $130 | $9 |
2022: 9 drugs
| Ciprofloxacin-Dexamethasone | 18 | $2,869 | $159 |
| Ipratropium | 48 | $2,745 | $57 |
| Azelastine | 19 | $662 | $35 |
| Fluticasone Propionate | 21 | $572 | $27 |
| Doxycycline Hyclate | 19 | $369 | $19 |
| Clotrimazole-Betamethasone | 18 | $328 | $18 |
| Amoxicillin-Clavulanate Potass | 21 | $310 | $15 |
| Prednisone | 11 | $159 | $14 |
| Hydrocodone-Acetaminophen | 15 | $91 | $6 |
2021: 4 drugs
| Ipratropium | 53 | $4,362 | $82 |
| Ciprofloxacin-Dexamethasone | 17 | $2,803 | $165 |
| Fluticasone Propionate | 30 | $556 | $19 |
| Omeprazole | 11 | $135 | $12 |
2020: 6 drugs
| Ciprodex | 13 | $3,349 | $258 |
| Ipratropium | 22 | $1,687 | $77 |
| Fluticasone Propionate | 21 | $394 | $19 |
| Clotrimazole-Betamethasone | 16 | $187 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $137 | $9 |
| Prednisone | 13 | $106 | $8 |
2019: 6 drugs
| Ciprodex | 11 | $2,720 | $247 |
| Ipratropium | 18 | $1,022 | $57 |
| Fluticasone Propionate | 41 | $594 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $195 | $13 |
| Doxycycline Hyclate | 14 | $178 | $13 |
| Prednisone | 15 | $157 | $10 |
2018: 8 drugs
| Ciprodex | 13 | $2,897 | $223 |
| Mometasone Furoate | 13 | $2,790 | $215 |
| Ipratropium | 34 | $1,551 | $46 |
| Azelastine | 17 | $1,476 | $87 |
| Fluticasone Propionate | 52 | $648 | $12 |
| Amoxicillin-Clavulanate Potass | 27 | $365 | $14 |
| Prednisone | 18 | $160 | $9 |
| Hydrocodone-Acetaminophen | 15 | $140 | $9 |
2017: 8 drugs
| Ciprodex | 22 | $4,455 | $202 |
| Ipratropium | 37 | $1,885 | $51 |
| Azelastine | 15 | $1,504 | $100 |
| Fluticasone Propionate | 44 | $657 | $15 |
| Amoxicillin-Clavulanate Potass | 29 | $617 | $21 |
| Prednisone | 16 | $135 | $8 |
| Amoxicillin | 15 | $112 | $7 |
| Hydrocodone-Acetaminophen | 13 | $83 | $6 |
2016: 9 drugs
| Nasonex | 19 | $7,143 | $376 |
| Mometasone Furoate | 15 | $4,880 | $325 |
| Ciprodex | 19 | $3,558 | $187 |
| Azelastine | 16 | $2,346 | $147 |
| Amoxicillin-Clavulanate Potass | 39 | $770 | $20 |
| Fluticasone Propionate | 45 | $664 | $15 |
| Ipratropium | 17 | $539 | $32 |
| Omeprazole | 11 | $161 | $15 |
| Levofloxacin | 12 | $158 | $13 |
2015: 8 drugs
| Nasonex | 63 | $19,761 | $314 |
| Azelastine | 13 | $2,512 | $193 |
| Ciprodex | 12 | $2,111 | $176 |
| Dymista | 11 | $1,863 | $169 |
| Ipratropium | 20 | $670 | $34 |
| Fluticasone Propionate | 46 | $666 | $14 |
| Amoxicillin-Clavulanate Potass | 22 | $285 | $13 |
| Omeprazole | 13 | $183 | $14 |
2014: 9 drugs
| Nasonex | 85 | $22,812 | $268 |
| Nexium | 13 | $6,215 | $478 |
| Ciprodex | 30 | $4,739 | $158 |
| Ipratropium | 26 | $1,044 | $40 |
| Fluticasone Propionate | 26 | $640 | $25 |
| Amox Tr-Potassium Clavulanate | 43 | $624 | $15 |
| Hydrocodone-Acetaminophen | 28 | $467 | $17 |
| Prednisone | 14 | $133 | $9 |
| Amoxicillin | 11 | $82 | $7 |
2013: 9 drugs
| Nasonex | 74 | $17,262 | $233 |
| Nexium | 18 | $8,471 | $471 |
| Ciprodex | 22 | $3,273 | $149 |
| Astepro | 14 | $2,218 | $158 |
| Fluticasone Propionate | 17 | $794 | $47 |
| Ipratropium | 18 | $560 | $31 |
| Amox Tr-Potassium Clavulanate | 25 | $535 | $21 |
| Hydrocodone-Acetaminophen | 13 | $279 | $21 |
| Prednisone | 12 | $80 | $7 |
Money from drug and device companies
$241 in 2025
| 2025 | 2 | 16 | None | $241 |
| 2024 | 4 | 21 | None | $445 |
| 2023 | 6 | 21 | None | $421 |
| 2022 | 6 | 11 | None | $268 |
| 2021 | 10 | 37 | None | $3,088 |
| 2020 | 3 | 9 | $2,250 | $2,803 |
| 2019 | 7 | 37 | $3,000 | $7,454 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $171 | 13 payments
|
| Genzyme | Dupixent | $71 | 3 payments
|
See all 16 published payments
| GlaxoSmithKline | Meals · 2025-12-16 | Nucala | $17 |
| GlaxoSmithKline | Meals · 2025-12-03 | Nucala | $15 |
| GlaxoSmithKline | Meals · 2025-10-30 | Nucala | $12 |
| Genzyme | Meals · 2025-10-23 | Dupixent | $23 |
| GlaxoSmithKline | Meals · 2025-10-09 | Nucala | $13 |
| GlaxoSmithKline | Meals · 2025-09-12 | Nucala | $15 |
| GlaxoSmithKline | Meals · 2025-08-19 | Nucala | $10 |
| Genzyme | Meals · 2025-07-24 | Dupixent | $25 |
| GlaxoSmithKline | Meals · 2025-07-17 | Nucala | $12 |
| GlaxoSmithKline | Meals · 2025-06-11 | Nucala | $12 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $9 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $1 |
| GlaxoSmithKline | Meals · 2025-04-08 | Nucala | $19 |
| Genzyme | Meals · 2025-04-03 | Dupixent | $23 |
| GlaxoSmithKline | Meals · 2025-02-20 | Nucala | $25 |
| GlaxoSmithKline | Meals · 2025-02-12 | Nucala | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $445
| GlaxoSmithKline | Nucala | $234 | 16 payments
|
| Stryker | Hemopore | $154 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $35 | 2 payments
|
| Genzyme | Dupixent | $21 | 1 payment
|
2023: $421
| Stryker | Xpress Ent Dilation System | $150 | 3 payments
|
| GlaxoSmithKline | Nucala | $139 | 12 payments
|
| Genzyme | Dupixent | $44 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $33 | 1 payment
|
| Acclarent | Acclarent Aera | $31 | 2 payments
|
| Optinose US | Xhance | $24 | 1 payment
|
2022: $268
| Stryker | Medline Industries, Inc. | $80 | 3 payments
|
| GlaxoSmithKline | Nucala | $75 | 3 payments
|
| OptiNose US | Xhance | $40 | 2 payments
|
| Medtronic | Sinuva | $32 | 1 payment
|
| Genzyme | Dupixent | $27 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $16 | 1 payment
|
2021: $3,088
| Intersect ENT | Propel | $2,678 | 8 payments
|
| Optinose US | Xhance | $121 | 17 payments
|
| Stryker | Xpress Ent Dilation System | $79 | 2 payments
|
| GlaxoSmithKline | Nucala | $53 | 2 payments
|
| Davol | Progel | $48 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $31 | 1 payment
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Ethicon US | Harmonic | $21 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $18 | 1 payment
|
| Itamar Medical | Watchpat | $17 | 1 payment
|
2020: $2,803
| Intersect ENT | None | $2,678 | 3 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $95 | 3 payments
|
| Acclarent | Trudi | $30 | 2 payments
|
2019: $7,454
| Intersect ENT | Sinuva | $7,117 | 22 payments
|
| Stryker | Entellus - Fiagon Sinus Navigation System | $108 | 4 payments
|
| Aerin Medical | Vivaer Rf Stylus | $76 | 2 payments
|
| Acclarent | Acclarent Navwire Sinus Navigation Guidewire | $76 | 2 payments
|
| OptiNose US | Xhance | $42 | 2 payments
|
| Cook Medical | Cook Medical Sleep | $19 | 1 payment
|
| Osteomed | Cmf-Cfx | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1205909603
- Licence
- CA G81045California G81045: Current · expires 2027-03-31
- Trained
- Tufts University School of Medicine, 1993 · 33 years ago
- Group
- Bass Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G810450
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 1000 S Eliseo Dr, # 103, Greenbrae, CA, 94904
- NPI first listed
- 2006-11-16
- NPI last updated
- 2025-01-02
- NPI record certified
- 2025-01-02
This is when the NPI record was last certified, not a medical board exam.